Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
For information on drug expiration / generic availability
— Pharmacist, USA
To find molecules near to the expiration of their patent rights
— Pharmceutical sales, India
For drug patent information
— Pharmaceutical business developer, USA
To identify drugs going off patent in the next five years
— Pharmaceutical product development coordinator, Indonesia
To plan ahead for inventory purposes
— Pharmacy purchaser, USA
Generated: May 27, 2017
Which patents cover Hydromox R, and when can generic versions of Hydromox R launch?
Hydromox R is a drug marketed by Lederle and is included in one NDA.| Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: see list | 47 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | HYDROMOX R at DailyMed |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | HYDROMOX R | quinethazone; reserpine | TABLET;ORAL | 013927-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents
Available with subscription
Paragraph IV Activity
Available with subscription
Patent Maintenance
Available with subscription
Non-Orange Book Patents
Available with subscription
International Patents
Available with subscription
Supplementary Protection Certificates
Available with subscription
For drug patent expirations and intelligence
— Analyst, USA
To get information on international drug patents
— Patent agent, USA
To have rapid access to API suppliers, generic drug manufacturers, and patent information pertaining to any given drug product or drug substance.
— Pharmaceutical consulting, USA
For information on medications and their innovator companies, as well as their patency profiles
— Pharmacist, Nigeria
To get information on brands we work on currently or could potentially work on
— Marketing professional, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
